Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$475,145
New position
Shares Held
3,167
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#370
of 594 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Polymer Capital Management (US) LLC holds $5,490,134 across 9 Diagnostics & Research names. GH ranks #8 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
8,132 | $1,548,983 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
549 | $701,352 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
2,987 | $577,148 | |
| 4 | NTRA |
Natera, Inc.
|
1,968 | $534,213 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
991 | $524,823 | |
| 6 | ILMN |
Illumina, Inc.
|
2,959 | $520,280 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
1,018 | $510,384 | |
| 8 | GH |
Guardant Health, Inc.
This page
|
3,167 | $475,145 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $475,145 | 3,167 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||